HEADER RHINOVIRUS COAT PROTEIN 18-FEB-88 1RS1 OBSLTE 15-JAN-90 1RS1 2RS1 TITLE STRUCTURAL ANALYSIS OF A SERIES OF ANTIVIRAL AGENTS TITLE 2 COMPLEXED WITH HUMAN RHINOVIRUS 14 COMPND MOL_ID: 1; COMPND 2 MOLECULE:; COMPND 3 CHAIN: 1; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE:; COMPND 7 CHAIN: 2; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE:; COMPND 11 CHAIN: 3; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 4; COMPND 14 MOLECULE:; COMPND 15 CHAIN: 4; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 MOL_ID: 2; SOURCE 3 MOL_ID: 3; SOURCE 4 MOL_ID: 4 KEYWDS RHINOVIRUS COAT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.BADGER,T.J.SMITH,M.G.ROSSMANN REVDAT 2 15-JAN-90 1RS1 3 OBSLTE REVDAT 1 09-OCT-88 1RS1 0 JRNL AUTH J.BADGER,I.MINOR,M.J.KREMER,M.A.OLIVEIRA,T.J.SMITH, JRNL AUTH 2 J.P.GRIFFITH,D.M.A.GUERIN,S.KRISHNASWAMY,M.LUO, JRNL AUTH 3 M.G.ROSSMANN,M.A.MCKINLAY,G.D.DIANA,F.J.DUTKO, JRNL AUTH 4 M.FANCHER,R.R.RUECKERT,B.A.HEINZ JRNL TITL STRUCTURAL ANALYSIS OF A SERIES OF ANTIVIRAL JRNL TITL 2 AGENTS COMPLEXED WITH HUMAN RHINOVIRUS 14 JRNL REF PROC.NATL.ACAD.SCI.USA V. 85 3304 1988 JRNL REFN ASTM PNASA6 US ISSN 0027-8424 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.ARNOLD,M.G.ROSSMANN REMARK 1 TITL THE USE OF MOLECULAR REPLACEMENT PHASES FOR THE REMARK 1 TITL 2 REFINEMENT OF THE HUMAN RHINOVIRUS 14 STRUCTURE REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH E.ARNOLD,M.G.ROSSMANN REMARK 1 TITL ANALYSIS OF THE STRUCTURE OF HUMAN RHINOVIRUS 14 REMARK 1 TITL 2 REFINED AT A RESOLUTION OF 3.0 ANGSTROMS REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 3 REMARK 1 AUTH E.ARNOLD,G.VRIEND,M.LUO,J.P.GRIFFITH,G.KAMER, REMARK 1 AUTH 2 J.W.ERICKSON,J.E.JOHNSON,M.G.ROSSMANN REMARK 1 TITL THE STRUCTURE DETERMINATION OF A COMMON COLD REMARK 1 TITL 2 VIRUS, HUMAN RHINOVIRUS 14 REMARK 1 REF ACTA CRYSTALLOGR.,SECT.A V. 43 346 1987 REMARK 1 REFN ASTM ACACEQ DK ISSN 0108-7673 REMARK 1 REFERENCE 4 REMARK 1 AUTH E.ARNOLD,M.LUO,G.VRIEND,M.G.ROSSMANN, REMARK 1 AUTH 2 A.C.PALMENBERG,G.D.PARKS,M.J.H.NICKLIN,E.WIMMER REMARK 1 TITL IMPLICATIONS OF THE PICORNAVIRUS CAPSID STRUCTURE REMARK 1 TITL 2 FOR POLYPROTEIN STRUCTURE REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 84 21 1987 REMARK 1 REFN ASTM PNASA6 US ISSN 0027-8424 REMARK 1 REFERENCE 5 REMARK 1 AUTH T.J.SMITH,M.J.KREMER,M.LUO,G.VRIEND,E.ARNOLD, REMARK 1 AUTH 2 G.KAMER,M.G.ROSSMANN,M.A.MCKINLAY,G.D.DIANA, REMARK 1 AUTH 3 M.J.OTTO REMARK 1 TITL THE SITE OF ATTACHMENT IN HUMAN RHINOVIRUS 14 FOR REMARK 1 TITL 2 ANTIVIRAL AGENTS THAT INHIBIT UNCOATING REMARK 1 REF SCIENCE V. 233 1286 1986 REMARK 1 REFN ASTM SCIEAS US ISSN 0036-8075 REMARK 1 REFERENCE 6 REMARK 1 AUTH M.G.ROSSMANN,E.ARNOLD,J.W.ERICKSON, REMARK 1 AUTH 2 E.A.FRANKENBERGER,J.P.GRIFFITH,H.-J.HECHT, REMARK 1 AUTH 3 J.E.JOHNSON,G.KAMER,M.LUO,G.VRIEND REMARK 1 TITL THE STRUCTURE OF A HUMAN COMMON COLD VIRUS REMARK 1 TITL 2 (RHINOVIRUS 14) AND ITS EVOLUTIONARY RELATIONS TO REMARK 1 TITL 3 OTHER VIRUSES REMARK 1 REF CHEM.SCR.,SECT.B V. 26 313 1987 REMARK 1 REFN ASTM CSRPB9 SW ISSN 0004-2056 REMARK 1 REFERENCE 7 REMARK 1 AUTH M.G.ROSSMANN,E.ARNOLD,J.W.ERICKSON, REMARK 1 AUTH 2 E.A.FRANKENBERGER,J.P.GRIFFITH,H.-J.HECHT, REMARK 1 AUTH 3 J.E.JOHNSON,G.KAMER,M.LUO,A.G.MOSSER,R.R.RUECKERT, REMARK 1 AUTH 4 B.SHERRY,G.VRIEND REMARK 1 TITL STRUCTURE OF A HUMAN COMMON COLD VIRUS AND REMARK 1 TITL 2 FUNCTIONAL RELATIONSHIP TO OTHER PICORNAVIRUSES REMARK 1 REF NATURE V. 317 145 1985 REMARK 1 REFN ASTM NATUAS UK ISSN 0028-0836 REMARK 1 REFERENCE 8 REMARK 1 AUTH E.ARNOLD,J.W.ERICKSON,G.S.FOUT,E.A.FRANKENBERGER, REMARK 1 AUTH 2 H.-J.HECHT,M.LUO,M.G.ROSSMANN,R.R.RUECKERT REMARK 1 TITL VIRION ORIENTATION IN CUBIC CRYSTALS OF THE HUMAN REMARK 1 TITL 2 COMMON COLD VIRUS /HRV14 REMARK 1 REF J.MOL.BIOL. V. 177 417 1984 REMARK 1 REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REFERENCE 9 REMARK 1 AUTH M.LUO,E.ARNOLD,J.W.ERICKSON,M.G.ROSSMANN,U.BOEGE, REMARK 1 AUTH 2 D.G.SCRABA REMARK 1 TITL PICORNAVIRUSES OF TWO DIFFERENT GENERA HAVE REMARK 1 TITL 2 SIMILAR STRUCTURES REMARK 1 REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REFERENCE 10 REMARK 1 AUTH J.W.ERICKSON,E.A.FRANKENBERGER,M.G.ROSSMANN, REMARK 1 AUTH 2 G.S.FOUT,K.C.MEDAPPA,R.R.RUECKERT REMARK 1 TITL CRYSTALLIZATION OF A COMMON COLD VIRUS, HUMAN REMARK 1 TITL 2 RHINOVIRUS 14. (QUOTE)ISOMORPHISM(QUOTE) WITH REMARK 1 TITL 3 POLIOVIRUS CRYSTALS REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 80 931 1983 REMARK 1 REFN ASTM PNASA6 US ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. NULL ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6268 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 271 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1RS1 COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 1RS1 THE VIRUS PARTICLE HAS A PROTEIN SHELL WITH REMARK 5 ICOSAHEDRAL 1RS1 SYMMETRY AROUND A CRYSTALLOGRAPHICALLY REMARK 5 DISORDERED CORE OF 1RS1 RNA. EACH ICOSAHEDRAL UNIT CONTAINS REMARK 5 FOUR PROTEIN SUBUNITS 1RS1 IDENTIFIED AS VP1, VP2, VP3, VP4 REMARK 5 BY THE DEPOSITORS. THE 1RS1 FOUR SUBUNITS HAVE BEEN REMARK 5 ASSIGNED CHAIN IDENTIFIERS *1*, 1RS1 *2*, *3*, *4* IN THIS REMARK 5 ENTRY. TO GENERATE A VIRAL SHELL 1RS1 FROM THE COORDINATES REMARK 5 GIVEN BELOW REQUIRES GENERATING THE 1RS1 OTHER ICOSAHEDRAL REMARK 5 UNITS. THIS IS ACCOMPLISHED BY APPLYING 1RS1 THE 532 POINT REMARK 5 GROUP SYMMETRY ELEMENTS IN THE SPECIFIC ORDER 1RS1 5X2X2X3 REMARK 5 ABOUT SPECIFIC AXES WHOSE TRANSFORMATIONS ARE 1RS1 GIVEN REMARK 5 BELOW. THE FOLLOWING FOUR STEPS ARE TO BE APPLIED TO 1RS1 REMARK 5 EACH POLYPEPTIDE CHAIN. EACH OF THE TOTAL OF 60 SYMMETRY REMARK 5 1RS1 OPERATIONS IS DERIVED BY CONSECUTIVE APPLICATION OF REMARK 5 THE 1RS1 ROTATIONAL SYMMETRY OPERATORS. 1RS1 1RS1 LET P1 = REMARK 5 COORDINATES OF ANY ATOM AS LISTED IN ENTRY 1RS1 1RS1 1. REMARK 5 1RS1 TRNSF1 1 .500000 -.809017 .309017 1RS1 TRNSF2 1 REMARK 5 .809017 .309017 -.500000 1RS1 TRNSF3 1 .309017 .500000 REMARK 5 .809017 1RS1 1RS1 APPLY THE FIVE-FOLD GIVEN BY TRNSF 1 1RS1 REMARK 5 1RS1 P2 = TRNSF 1 * P1 1RS1 P3 = TRNSF 1 * P2 1RS1 P4 = REMARK 5 TRNSF 1 * P3 1RS1 P5 = TRNSF 1 * P4 1RS1 1RS1 P1 THROUGH P5 REMARK 5 CONSTITUTE AN ENTIRE PENTAMER, 1RS1 CONSISTING OF FIVE REMARK 5 PROTOMERIC UNITS. ONE COMPLETE 1RS1 PENTAMER SET OF REMARK 5 COORDINATES WILL CONTAIN FIVE CHAINS 1RS1 EACH OF VP1, VP2, REMARK 5 VP3, AND VP4. 1RS1 1RS1 2. 1RS1 1RS1 TRNSF1 2 .309017 - REMARK 5 .500000 .809017 1RS1 TRNSF2 2 -.500000 -.809017 -.309017 REMARK 5 1RS1 TRNSF3 2 .809017 -.309017 -.500000 1RS1 1RS1 APPLY THE REMARK 5 TWO-FOLD GIVEN BY TRNSF 2 TO P1 THROUGH P5 1RS1 TO GENERATE REMARK 5 P6 THROUGH P10 FOR A SECOND ENTIRE 1RS1 PENTAMER. 1RS1 1RS1 REMARK 5 P6 = TRNSF 2 * P1 1RS1 P7 = TRNSF 2 * P2 1RS1 P8 = TRNSF 2 REMARK 5 * P3 1RS1 P9 = TRNSF 2 * P4 1RS1 P10 = TRNSF 2 * P5 1RS1 REMARK 5 1RS1 3. 1RS1 1RS1 TRNSF1 3 -.500000 -.809017 .309017 1RS1 REMARK 5 TRNSF2 3 -.809017 .309017 -.500000 1RS1 TRNSF3 3 .309017 - REMARK 5 .500000 -.809017 1RS1 1RS1 APPLY THE TWO-FOLD GIVEN BY REMARK 5 TRNSF 3 TO EACH OF THE 1RS1 FIRST TEN PROTOMERS (WILL YIELD REMARK 5 TOTAL OF TWENTY 1RS1 UNITS, FOUR COMPLETE PENTAMERS). FOR REMARK 5 EXAMPLE, 1RS1 1RS1 P11 = TRNSF 3 * P1 1RS1 P14 = TRSNF 3 * REMARK 5 P4 1RS1 P16 = TRNSF 3 * P6 1RS1 P20 = TRNSF 3 * P10 1RS1 REMARK 5 1RS1 4. 1RS1 1RS1 TRNSF1 4 .000000 .000000 1.000000 1RS1 REMARK 5 TRNSF2 4 1.000000 .000000 .000000 1RS1 TRNSF3 4 .000000 REMARK 5 1.000000 .000000 1RS1 1RS1 FIRST, APPLY THE THREE-FOLD REMARK 5 GIVEN BY TRNSF 4 TO EACH 1RS1 OF THE TWENTY PROTOMERS P1 REMARK 5 THROUGH P20 TO GENERATE 1RS1 PROTOMERS P21 THROUGH P40. FOR REMARK 5 EXAMPLE, 1RS1 1RS1 P21 = TRNSF 4 * P2 1RS1 P22 = TRNSF 4 * REMARK 5 P2 1RS1 P31 = TRNSF 4 * P11 1RS1 P40 = TRNSF 4 * P20 1RS1 REMARK 5 1RS1 FINALLY, PROTOMERS P41 THROUGH P60 MAY BE GENERATED REMARK 5 1RS1 BY APPLYING TRNSF 4 TO PROTOMERS P21 THROUGH P40. 1RS1 REMARK 5 FOR EXAMPLE, 1RS1 1RS1 P41 = TRNSF 4 * P21 1RS1 P42 = TRNSF REMARK 5 4 * P22 1RS1 P51 = TRNSF 4 * P31 1RS1 P60 = TRNSF 4 * P40 REMARK 5 1RS1 1RS1 1RS1 THIS YIELDS A TOTAL OF 60 PROTOMERS IN AN REMARK 5 ICOSAHEDRAL 1RS1 VIRION. 1RS1 REMARK 6 REMARK 6 1RS1 TO OBTAIN THE FRACTIONAL CRYSTALLOGRAPHIC COORDINATES REMARK 6 1RS1 XCRYST FROM THE CARTESIAN MOLECULAR COORDINATES XCART REMARK 6 1RS1 GENERATED ABOVE ONE USES 1RS1 1RS1 XCRYST = REMARK 6 (CARTCRYST) * XCART + X0 1RS1 1RS1 WHERE THE MATRIX REMARK 6 (CARTCRYST) TRANSFORMS CARTESIAN 1RS1 COORDINATES TO REMARK 6 FRACTIONAL CRYSTAL COORDINATES AND X0 IS THE 1RS1 CENTER REMARK 6 POSITION OF PARTICLE 1. THE MATRIX (CARTCRYST) IS 1RS1 THE REMARK 6 PRODUCT OF A MATRIX (SHRINK) WHICH CONVERTS FROM 1RS1 REMARK 6 CARTESIAN TO FRACTIONAL AND A ROTATION MATRIX (ROTATE) 1RS1 REMARK 6 WHICH ROTATES THE MOLECULAR COORDINATES BY -6.10 DEGREES REMARK 6 1RS1 ABOUT THE CUBIC BODY DIAGONAL AXIS. 1RS1 1RS1 .996225 REMARK 6 -.059464 .063239 1RS1 (ROTATE) = .063239 .996225 -.059464 REMARK 6 1RS1 -.059464 .063239 .996225 1RS1 1RS1 A* 0 0 1RS1 REMARK 6 (SHRINK) = 0 A* 0 1RS1 0 0 A* 1RS1 1RS1 SO (CARTCRYST) = REMARK 6 (SHRINK) * (ROTATE) WHICH IS PRESENTED ON 1RS1 *SCALE* REMARK 6 RECORDS BELOW. THE VALUE OF THE PARTICLE POSITION 1RS1 X0 REMARK 6 WHICH WAS USED FOR THE STRUCTURE DETERMINATION WAS 1RS1 X = REMARK 6 Y = Z = 0.00039 (FRACTIONAL COORDINATES). 1RS1 1RS1 REMARK 6 FRACTIONAL CRYSTAL COORDINATES FOR ATOMS IN THE REFERENCE REMARK 6 1RS1 PARTICLE (NUMBER 1) MAY BE GENERATED IN THIS WAY FOR REMARK 6 EACH 1RS1 OF THE 60 PROTOMERIC UNITS P1 - P60 OBTAINED REMARK 6 ABOVE. THE 1RS1 OTHER PARTICLES ARE BUILT BY APPLICATION OF REMARK 6 THE 2(1) SCREW 1RS1 AXES OF THE P2(1)3 SPACE GROUP, NAMELY REMARK 6 1RS1 1RS1 PARTICLE I. X, Y, Z 1RS1 PARTICLE II. 1/2+X, 1/2- REMARK 6 Y, -Z 1RS1 PARTICLE III. -X, 1/2+Y, 1/2-Z 1RS1 PARTICLE IV. REMARK 6 1/2-X, -Y, 1/2+Z 1RS1 REMARK 7 REMARK 7 1RS1 THERE IS A BIFURCATED SHEET IN EACH OF CHAINS *1*, *2* REMARK 7 , AND 1RS1 *3*. TO REPRESENT THIS FEATURE REDUNDANT SHEETS REMARK 7 ARE 1RS1 DEFINED. THUS SHEETS B11 AND B12 DIFFER ONLY IN REMARK 7 STRAND 4, 1RS1 SHEETS B12 AND B22 DIFFER ONLY IN STRAND 4, REMARK 7 AND SHEETS B13 1RS1 AND B23 DIFFER IN STRANDS 1 AND 4 REMARK 7 (DOUBLY BIFURCATED). 1RS1 REMARK 8 REMARK 8 1RS1 THERE ARE EIGHT STUDIES OF DRUGS BOUND TO RHINOVIRUS REMARK 8 THAT 1RS1 HAVE BEEN DEPOSITED WITH THE PROTEIN DATA BANK. REMARK 8 THESE 1RS1 ENTRIES ARE IDENTIFIED AS 1RS1, 1RR1, 1RM2, REMARK 8 1RS3, 1R04, 1RS1 1RS5, 1R06, AND 1R07. CONSIDERABLE REMARK 8 CONFORMATIONAL 1RS1 DIFFERENCES EXIST BETWEEN THE NATIVE REMARK 8 RHINOVIRUS AND THE 1RS1 VIRUS CONTAINING THE DRUG REMARK 8 MOLECULES. HOWEVER BECAUSE THE 1RS1 STRUCTURES OF THE REMARK 8 VARIOUS RHINOVIRUS/DRUG COMPLEXES ARE NOT 1RS1 DETECTABLY REMARK 8 DIFFERENT FROM EACH OTHER THE COORDINATES OF THE 1RS1 VIRUS REMARK 8 ARE ONLY PRESENTED ONCE, IN ENTRY 1RS1. IN ADDITION, 1RS1 REMARK 8 SOME RECORDS ARE OMITTED FROM ALL ENTRIES EXCEPT 1RS1 1RS1 REMARK 8 (REMARK 1, SEQRES, FTNOTE, HELIX, SHEET). 1RS1 REMARK 9 REMARK 9 1RS1 THE ATOM NAMES PROVIDED BY THE DEPOSITORS CONTAINED REMARK 9 1RS1 SPECIAL CHARACTERS WHICH HAVE BEEN REPLACED AS 1RS1 REMARK 9 FOLLOWS IN THE ATOM NAMES ON HETATM RECORDS BELOW - 1RS1 REMARK 9 SINGLE QUOTE A 1RS1 ASTERISK B 1RS1 NUMBER SIGN C 1RS1 REMARK 10 REMARK 10 1RS1 CORRECTION. THIS ENTRY IS OBSOLETE. 15-JAN-90. 1RS1 REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 1/2-X,-Y,1/2+Z REMARK 290 3555 -X,1/2+Y,1/2-Z REMARK 290 4555 1/2+X,1/2-Y,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 1/2+Z,1/2-X,-Y REMARK 290 7555 1/2-Z,-X,1/2+Y REMARK 290 8555 -Z,1/2+X,1/2-Y REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,1/2+Z,1/2-X REMARK 290 11555 1/2+Y,1/2-Z,-X REMARK 290 12555 1/2-Y,-Z,1/2+X REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.992912 -0.007511 -0.118375 208.50313 REMARK 290 SMTRY2 2 -0.007566 -0.991983 0.126356 0.89155 REMARK 290 SMTRY3 2 -0.118845 0.125941 0.984895 235.84130 REMARK 290 SMTRY1 3 -0.991983 0.126356 -0.007566 0.89155 REMARK 290 SMTRY2 3 0.125941 0.984895 -0.118845 235.84130 REMARK 290 SMTRY3 3 -0.007511 -0.118375 -0.992912 208.50313 REMARK 290 SMTRY1 4 0.984895 -0.118845 0.125941 235.84130 REMARK 290 SMTRY2 4 -0.118375 -0.992912 -0.007511 208.50313 REMARK 290 SMTRY3 4 0.126356 -0.007566 -0.991983 0.89155 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 -0.118845 0.125941 0.984895 235.84130 REMARK 290 SMTRY2 6 -0.992912 -0.007511 -0.118375 208.50313 REMARK 290 SMTRY3 6 -0.007566 -0.991983 0.126356 0.89155 REMARK 290 SMTRY1 7 -0.007511 -0.118375 -0.992912 208.50313 REMARK 290 SMTRY2 7 -0.991983 0.126356 -0.007566 0.89155 REMARK 290 SMTRY3 7 0.125941 0.984895 -0.118845 235.84130 REMARK 290 SMTRY1 8 0.126356 -0.007566 -0.991983 0.89155 REMARK 290 SMTRY2 8 0.984895 -0.118845 0.125941 235.84130 REMARK 290 SMTRY3 8 -0.118375 -0.992912 -0.007511 208.50313 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 -0.007566 -0.991983 0.126356 0.89155 REMARK 290 SMTRY2 10 -0.118845 0.125941 0.984895 235.84130 REMARK 290 SMTRY3 10 -0.992912 -0.007511 -0.118375 208.50313 REMARK 290 SMTRY1 11 0.125941 0.984895 -0.118845 235.84130 REMARK 290 SMTRY2 11 -0.007511 -0.118375 -0.992912 208.50313 REMARK 290 SMTRY3 11 -0.991983 0.126356 -0.007566 0.89155 REMARK 290 SMTRY1 12 -0.118375 -0.992912 -0.007511 208.50313 REMARK 290 SMTRY2 12 0.126356 -0.007566 -0.991983 0.89155 REMARK 290 SMTRY3 12 0.984895 -0.118845 0.125941 235.84130 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 4 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: 1, 2, 3, 4 REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY 1 1 REMARK 465 LEU 1 2 REMARK 465 GLY 1 3 REMARK 465 ASP 1 4 REMARK 465 GLU 1 5 REMARK 465 LEU 1 6 REMARK 465 GLU 1 7 REMARK 465 GLU 1 8 REMARK 465 VAL 1 9 REMARK 465 ILE 1 10 REMARK 465 VAL 1 11 REMARK 465 GLU 1 12 REMARK 465 LYS 1 13 REMARK 465 THR 1 14 REMARK 465 LYS 1 15 REMARK 465 GLN 1 16 REMARK 465 SER 2 1 REMARK 465 PRO 2 2 REMARK 465 ASN 2 3 REMARK 465 VAL 2 4 REMARK 465 GLU 2 5 REMARK 465 ALA 2 6 REMARK 465 CYS 2 7 REMARK 465 GLY 4 1 REMARK 465 ALA 4 2 REMARK 465 GLN 4 3 REMARK 465 VAL 4 4 REMARK 465 SER 4 5 REMARK 465 THR 4 6 REMARK 465 GLN 4 7 REMARK 465 LYS 4 8 REMARK 465 SER 4 9 REMARK 465 GLY 4 10 REMARK 465 SER 4 11 REMARK 465 HIS 4 12 REMARK 465 GLU 4 13 REMARK 465 ASN 4 14 REMARK 465 GLN 4 15 REMARK 465 ASN 4 16 REMARK 465 ILE 4 17 REMARK 465 LEU 4 18 REMARK 465 THR 4 19 REMARK 465 ASN 4 20 REMARK 465 GLY 4 21 REMARK 465 SER 4 22 REMARK 465 ASN 4 23 REMARK 465 GLN 4 24 REMARK 465 THR 4 25 REMARK 465 PHE 4 26 REMARK 465 THR 4 27 REMARK 465 VAL 4 28 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 ND2 ASN 1 105 O HOH 258 1.23 REMARK 500 O HOH 115 O HOH 695 1.66 REMARK 500 O HOH 139 O HOH 494 1.90 REMARK 500 NH1 ARG 2 192 O HOH 131 2.02 REMARK 500 OE1 GLU 3 236 O HOH 100 2.06 REMARK 500 OG SER 3 21 O HOH 22 2.07 REMARK 500 NH2 ARG 2 192 O HOH 71 2.17 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP 1 285 CA ASP 1 285 CB 0.265 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER 1 170 CA - CB - OG ANGL. DEV. = 30.1 DEGREES REMARK 500 LYS 2 87 CA - CB - CG ANGL. DEV. = 38.1 DEGREES REMARK 500 ASN 2 194 C - N - CA ANGL. DEV. = 28.5 DEGREES REMARK 500 ASP 3 50 CA - CB - CG ANGL. DEV. = 27.7 DEGREES REMARK 500 ASP 3 216 C - N - CA ANGL. DEV. = 27.5 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS 2 257 100.77 104.04 SEQRES 1 1 289 GLY LEU GLY ASP GLU LEU GLU GLU VAL ILE VAL GLU LYS SEQRES 2 1 289 THR LYS GLN THR VAL ALA SER ILE SER SER GLY PRO LYS SEQRES 3 1 289 HIS THR GLN LYS VAL PRO ILE LEU THR ALA ASN GLU THR SEQRES 4 1 289 GLY ALA THR MET PRO VAL LEU PRO SER ASP SER ILE GLU SEQRES 5 1 289 THR ARG THR THR TYR MET HIS PHE ASN GLY SER GLU THR SEQRES 6 1 289 ASP VAL GLU CYS PHE LEU GLY ARG ALA ALA CYS VAL HIS SEQRES 7 1 289 VAL THR GLU ILE GLN ASN LYS ASP ALA THR GLY ILE ASP SEQRES 8 1 289 ASN HIS ARG GLU ALA LYS LEU PHE ASN ASP TRP LYS ILE SEQRES 9 1 289 ASN LEU SER SER LEU VAL GLN LEU ARG LYS LYS LEU GLU SEQRES 10 1 289 LEU PHE THR TYR VAL ARG PHE ASP SER GLU TYR THR ILE SEQRES 11 1 289 LEU ALA THR ALA SER GLN PRO ASP SER ALA ASN TYR SER SEQRES 12 1 289 SER ASN LEU VAL VAL GLN ALA MET TYR VAL PRO PRO GLY SEQRES 13 1 289 ALA PRO ASN PRO LYS GLU TRP ASP ASP TYR THR TRP GLN SEQRES 14 1 289 SER ALA SER ASN PRO SER VAL PHE PHE LYS VAL GLY ASP SEQRES 15 1 289 THR SER ARG PHE SER VAL PRO TYR VAL GLY LEU ALA SER SEQRES 16 1 289 ALA TYR ASN CYS PHE TYR ASP GLY TYR SER HIS ASP ASP SEQRES 17 1 289 ALA GLU THR GLN TYR GLY ILE THR VAL LEU ASN HIS MET SEQRES 18 1 289 GLY SER MET ALA PHE ARG ILE VAL ASN GLU HIS ASP GLU SEQRES 19 1 289 HIS LYS THR LEU VAL LYS ILE ARG VAL TYR HIS ARG ALA SEQRES 20 1 289 LYS HIS VAL GLU ALA TRP ILE PRO ARG ALA PRO ARG ALA SEQRES 21 1 289 LEU PRO TYR THR SER ILE GLY ARG THR ASN TYR PRO LYS SEQRES 22 1 289 ASN THR GLU PRO VAL ILE LYS LYS ARG LYS GLY ASP ILE SEQRES 23 1 289 LYS SER TYR SEQRES 1 2 262 SER PRO ASN VAL GLU ALA CYS GLY TYR SER ASP ARG VAL SEQRES 2 2 262 GLN GLN ILE THR LEU GLY ASN SER THR ILE THR THR GLN SEQRES 3 2 262 GLU ALA ALA ASN ALA VAL VAL CYS TYR ALA GLU TRP PRO SEQRES 4 2 262 GLU TYR LEU PRO ASP VAL ASP ALA SER ASP VAL ASN LYS SEQRES 5 2 262 THR SER LYS PRO ASP THR SER VAL CYS ARG PHE TYR THR SEQRES 6 2 262 LEU ASP SER LYS THR TRP THR THR GLY SER LYS GLY TRP SEQRES 7 2 262 CYS TRP LYS LEU PRO ASP ALA LEU LYS ASP MET GLY VAL SEQRES 8 2 262 PHE GLY GLN ASN MET PHE PHE HIS SER LEU GLY ARG SER SEQRES 9 2 262 GLY TYR THR VAL HIS VAL GLN CYS ASN ALA THR LYS PHE SEQRES 10 2 262 HIS SER GLY CYS LEU LEU VAL VAL VAL ILE PRO GLU HIS SEQRES 11 2 262 GLN LEU ALA SER HIS GLU GLY GLY ASN VAL SER VAL LYS SEQRES 12 2 262 TYR THR PHE THR HIS PRO GLY GLU ARG GLY ILE ASP LEU SEQRES 13 2 262 SER SER ALA ASN GLU VAL GLY GLY PRO VAL LYS ASP VAL SEQRES 14 2 262 ILE TYR ASN MET ASN GLY THR LEU LEU GLY ASN LEU LEU SEQRES 15 2 262 ILE PHE PRO HIS GLN PHE ILE ASN LEU ARG THR ASN ASN SEQRES 16 2 262 THR ALA THR ILE VAL ILE PRO TYR ILE ASN SER VAL PRO SEQRES 17 2 262 ILE ASP SER MET THR ARG HIS ASN ASN VAL SER LEU MET SEQRES 18 2 262 VAL ILE PRO ILE ALA PRO LEU THR VAL PRO THR GLY ALA SEQRES 19 2 262 THR PRO SER LEU PRO ILE THR VAL THR ILE ALA PRO MET SEQRES 20 2 262 CYS THR GLU PHE SER GLY ILE ARG SER LYS SER ILE VAL SEQRES 21 2 262 PRO GLN SEQRES 1 3 236 GLY LEU PRO THR THR THR LEU PRO GLY SER GLY GLN PHE SEQRES 2 3 236 LEU THR THR ASP ASP ARG GLN SER PRO SER ALA LEU PRO SEQRES 3 3 236 ASN TYR GLU PRO THR PRO ARG ILE HIS ILE PRO GLY LYS SEQRES 4 3 236 VAL HIS ASN LEU LEU GLU ILE ILE GLN VAL ASP THR LEU SEQRES 5 3 236 ILE PRO MET ASN ASN THR HIS THR LYS ASP GLU VAL ASN SEQRES 6 3 236 SER TYR LEU ILE PRO LEU ASN ALA ASN ARG GLN ASN GLU SEQRES 7 3 236 GLN VAL PHE GLY THR ASN LEU PHE ILE GLY ASP GLY VAL SEQRES 8 3 236 PHE LYS THR THR LEU LEU GLY GLU ILE VAL GLN TYR TYR SEQRES 9 3 236 THR HIS TRP SER GLY SER LEU ARG PHE SER LEU MET TYR SEQRES 10 3 236 THR GLY PRO ALA LEU SER SER ALA LYS LEU ILE LEU ALA SEQRES 11 3 236 TYR THR PRO PRO GLY ALA ARG GLY PRO GLN ASP ARG ARG SEQRES 12 3 236 GLU ALA MET LEU GLY THR HIS VAL VAL TRP ASP ILE GLY SEQRES 13 3 236 LEU GLN SER THR ILE VAL MET THR ILE PRO TRP THR SER SEQRES 14 3 236 GLY VAL GLN PHE ARG TYR THR ASP PRO ASP THR TYR THR SEQRES 15 3 236 SER ALA GLY PHE LEU SER CYS TRP TYR GLN THR SER LEU SEQRES 16 3 236 ILE LEU PRO PRO GLU THR THR GLY GLN VAL TYR LEU LEU SEQRES 17 3 236 SER PHE ILE SER ALA CYS PRO ASP PHE LYS LEU ARG LEU SEQRES 18 3 236 MET LYS ASP THR GLN THR ILE SER GLN THR VAL ALA LEU SEQRES 19 3 236 THR GLU SEQRES 1 4 68 GLY ALA GLN VAL SER THR GLN LYS SER GLY SER HIS GLU SEQRES 2 4 68 ASN GLN ASN ILE LEU THR ASN GLY SER ASN GLN THR PHE SEQRES 3 4 68 THR VAL ILE ASN TYR TYR LYS ASP ALA ALA SER THR SER SEQRES 4 4 68 SER ALA GLY GLN SER LEU SER MET ASP PRO SER LYS PHE SEQRES 5 4 68 THR GLU PRO VAL LYS ASP LEU MET LEU LYS GLY ALA PRO SEQRES 6 4 68 ALA LEU ASN FTNOTE 1 RESIDUE PRO 2 83 IS A CIS PROLINE. HET W84 900 26 HETNAM W84 5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)-3- HETNAM 2 W84 METHYL ISOXAZOLE HETSYN W84 WIN I(S); WIN 52084 (S) FORMUL 5 W84 C21 H28 N2 O3 FORMUL 6 HOH *271(H2 O1) HELIX 1 HZ1 ASP 1 66 GLY 1 72 1 7 HELIX 2 HA1 VAL 1 110 PHE 1 119 1 10 HELIX 3 HB1 ASP 1 165 SER 1 170 1 6 HELIX 4 HZ2 PRO 2 56 CYS 2 61 1 6 HELIX 5 HA2 MET 2 89 HIS 2 99 1 11 HELIX 6 HB2 LEU 2 177 PHE 2 184 1 8 HELIX 7 HZ3 ASN 3 42 VAL 3 49 1 8 HELIX 8 HA3 THR 3 95 TYR 3 104 1 10 HELIX 9 HB3 ASP 3 141 GLY 3 148 1 8 SHEET 1 B11 4 ALA 1 75 ASN 1 84 0 SHEET 2 B11 4 THR 1 237 ILE 1 254 -1 SHEET 3 B11 4 THR 1 120 SER 1 135 -1 SHEET 4 B11 4 ASP 1 182 VAL 1 188 -1 SHEET 1 B21 4 ALA 1 75 ASN 1 84 0 SHEET 2 B21 4 THR 1 237 ILE 1 254 -1 SHEET 3 B21 4 THR 1 120 SER 1 135 -1 SHEET 4 B21 4 TYR 1 197 PHE 1 200 -1 SHEET 1 C11 4 ASN 1 100 ILE 1 104 0 SHEET 2 C11 4 GLY 1 222 VAL 1 229 -1 SHEET 3 C11 4 LEU 1 146 VAL 1 153 -1 SHEET 4 C11 4 PRO 1 174 VAL 1 180 -1 SHEET 1 A12 2 ARG 2 12 LEU 2 18 0 SHEET 2 A12 2 SER 2 21 ALA 2 28 -1 SHEET 1 B12 4 TYR 2 64 TRP 2 71 0 SHEET 2 B12 4 LEU 2 238 GLY 2 253 -1 SHEET 3 B12 4 SER 2 100 CYS 2 112 -1 SHEET 4 B12 4 ASN 2 195 ILE 2 201 -1 SHEET 1 B22 4 TYR 2 64 TRP 2 71 0 SHEET 2 B22 4 LEU 2 238 GLY 2 253 -1 SHEET 3 B22 4 SER 2 100 CYS 2 112 -1 SHEET 4 B22 4 ASP 2 210 MET 2 212 -1 SHEET 1 C12 4 GLY 2 77 LEU 2 82 0 SHEET 2 C12 4 VAL 2 218 THR 2 229 -1 SHEET 3 C12 4 SER 2 119 ILE 2 127 -1 SHEET 4 C12 4 PRO 2 185 LEU 2 191 -1 SHEET 1 B13 4 THR 3 51 ILE 3 53 0 SHEET 2 B13 4 VAL 3 205 LEU 3 221 -1 SHEET 3 B13 4 THR 3 105 THR 3 118 -1 SHEET 4 B13 4 SER 3 159 ILE 3 165 -1 SHEET 1 B23 4 ILE 3 69 LEU 3 71 0 SHEET 2 B23 4 VAL 3 205 LEU 3 221 -1 SHEET 3 B23 4 THR 3 105 THR 3 118 -1 SHEET 4 B23 4 ARG 3 174 THR 3 176 -1 SHEET 1 C13 4 PHE 3 81 LEU 3 85 0 SHEET 2 C13 4 GLY 3 185 ILE 3 196 -1 SHEET 3 C13 4 SER 3 124 THR 3 132 -1 SHEET 4 C13 4 THR 3 149 ILE 3 155 -1 CISPEP 1 LEU 2 82 PRO 2 83 0 2.69 CRYST1 445.100 445.100 445.100 90.00 90.00 90.00 P 21 3 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.002238 -0.000134 0.000142 0.00039 SCALE2 0.000142 0.002238 -0.000134 0.00039 SCALE3 -0.000134 0.000142 0.002238 0.00039